Banner (BANR) EPS Estimated At $0.77; 1492 Capital Management Trimmed Its Ani Pharmaceuticals (ANIP) Stake

Banner Corporation (NASDAQ:BANR) Logo

1492 Capital Management Llc decreased Ani Pharmaceuticals Inc (ANIP) stake by 18.49% reported in 2017Q4 SEC filing. 1492 Capital Management Llc sold 8,018 shares as Ani Pharmaceuticals Inc (ANIP)’s stock declined 8.99%. The 1492 Capital Management Llc holds 35,349 shares with $2.28 million value, down from 43,367 last quarter. Ani Pharmaceuticals Inc now has $678.34M valuation. The stock increased 0.22% or $0.13 during the last trading session, reaching $58.22. About 60,331 shares traded. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has risen 18.93% since March 31, 2017 and is uptrending. It has outperformed by 7.38% the S&P500.

Analysts expect Banner Corporation (NASDAQ:BANR) to report $0.77 EPS on April, 23.They anticipate $0.04 EPS change or 5.48% from last quarter’s $0.73 EPS. BANR’s profit would be $25.20M giving it 18.02 P/E if the $0.77 EPS is correct. After having $0.71 EPS previously, Banner Corporation’s analysts see 8.45% EPS growth. The stock decreased 0.20% or $0.11 during the last trading session, reaching $55.49. About 277,417 shares traded or 29.53% up from the average. Banner Corporation (NASDAQ:BANR) has risen 4.20% since March 31, 2017 and is uptrending. It has underperformed by 7.35% the S&P500.

Investors sentiment decreased to 1.09 in 2017 Q4. Its down 0.60, from 1.69 in 2017Q3. It dived, as 13 investors sold ANIP shares while 43 reduced holdings. 23 funds opened positions while 38 raised stakes. 6.25 million shares or 0.89% less from 6.31 million shares in 2017Q3 were reported. Bancorp Of New York Mellon Corporation holds 0% or 191,442 shares in its portfolio. Thrivent Financial For Lutherans reported 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Legal & General Gru Public Ltd Co has 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Proshare Advsr Lc stated it has 0% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Globeflex Cap LP accumulated 0.51% or 28,615 shares. Piermont Mgmt has 0.13% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Vanguard Grp Inc Inc holds 0% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 481,229 shares. Financial Bank Of America De accumulated 0% or 9,298 shares. Loomis Sayles And Communication Limited Partnership invested in 108 shares. Riverhead Limited invested 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Millennium Management Ltd Com invested 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Weiss Asset Mngmt LP stated it has 11,639 shares or 0.07% of all its holdings. Retail Bank Of Montreal Can accumulated 0% or 2,408 shares. Moreover, Ameriprise Fincl Inc has 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 53,045 shares. Us Bankshares De invested in 75 shares or 0% of the stock.

Since March 1, 2018, it had 0 buys, and 7 insider sales for $9.84 million activity. 27,964 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) shares with value of $1.74 million were sold by RAYNOR DANIEL. $120,647 worth of stock was sold by MARSHBANKS TRACY on Wednesday, March 14. 4,177 shares valued at $258,640 were sold by Marken James G. on Monday, March 5. On Thursday, March 1 the insider Schrepfer Robert W sold $1.77M. Another trade for 23,986 shares valued at $1.47 million was made by PRZYBYL ARTHUR on Thursday, March 1.

Analysts await ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) to report earnings on May, 3. They expect $1.10 earnings per share, up 77.42% or $0.48 from last year’s $0.62 per share. ANIP’s profit will be $12.82M for 13.23 P/E if the $1.10 EPS becomes a reality. After $1.00 actual earnings per share reported by ANI Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 10.00% EPS growth.

Among 6 analysts covering ANI Pharma (NASDAQ:ANIP), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. ANI Pharma has $82 highest and $50 lowest target. $66.20’s average target is 13.71% above currents $58.22 stock price. ANI Pharma had 20 analyst reports since July 31, 2015 according to SRatingsIntel. TH Capital maintained it with “Neutral” rating and $67 target in Tuesday, August 4 report. Canaccord Genuity maintained ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) on Wednesday, February 28 with “Buy” rating. The firm has “Strong Buy” rating by Raymond James given on Thursday, June 23. Canaccord Genuity maintained the stock with “Buy” rating in Monday, October 16 report. The company was initiated on Friday, November 13 by Standpoint Research. Oppenheimer maintained ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) on Friday, August 5 with “Outperform” rating. TH Capital downgraded the stock to “Neutral” rating in Wednesday, February 22 report. Roth Capital maintained ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) on Thursday, November 2 with “Hold” rating. TH Capital upgraded the stock to “Buy” rating in Monday, September 28 report. The stock of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has “Perform” rating given on Tuesday, July 19 by Oppenheimer.

Among 10 analysts covering Banner Corporation (NASDAQ:BANR), 3 have Buy rating, 0 Sell and 7 Hold. Therefore 30% are positive. Banner Corporation had 21 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was initiated by Piper Jaffray on Monday, September 28 with “Overweight”. The company was maintained on Thursday, December 21 by Keefe Bruyette & Woods. The firm earned “Mkt Perform” rating on Tuesday, October 11 by FBR Capital. The stock has “Hold” rating by Keefe Bruyette & Woods on Friday, July 7. The company was maintained on Friday, September 1 by Keefe Bruyette & Woods. On Friday, May 26 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. Piper Jaffray maintained the shares of BANR in report on Thursday, October 5 with “Buy” rating. The rating was downgraded by Keefe Bruyette & Woods on Friday, October 23 to “Market Perform”. Sandler O’Neill maintained Banner Corporation (NASDAQ:BANR) rating on Thursday, January 25. Sandler O’Neill has “Buy” rating and $62.0 target. The stock of Banner Corporation (NASDAQ:BANR) earned “Hold” rating by Piper Jaffray on Friday, February 2.

Banner Corporation operates as the bank holding firm for Banner Bank and Islanders Bank, which provides commercial banking and financial services and products to individuals, businesses, and public sector entities primarily in the United States. The company has market cap of $1.82 billion. It offers deposit products, including interest-bearing and non-interest-bearing checking accounts, money market deposit accounts, regular savings accounts, certificates of deposit, cash management services, and retirement savings plans. It has a 30.16 P/E ratio. The firm also provides commercial real estate loans, including owner-occupied, investment properties, and multifamily residential real estate; construction, land, and land development loans; residential mortgage loans; commercial business loans; agricultural loans; and consumer loans, such as home equity lines of credit, automobile, and boat and recreational vehicle loans, as well as loans secured by deposit accounts.

Banner Corporation (NASDAQ:BANR) Ratings Chart